ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

4.52
-0.235 (-4.94%)
24 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.235 -4.94% 4.52 4.35 4.69 4.75 4.36 4.75 212,429 16:35:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.58M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.76p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.58 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 6651 to 6675 of 99175 messages
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older
DateSubjectAuthorDiscuss
08/5/2020
06:35
Yes .... chart rang me last night...It's good ... Leicester bird was on it !!
amaretto1
07/5/2020
19:29
Does the chart know if the results are good or bad please !! Lol ?
paradise city
07/5/2020
19:02
Long term chart is up, news is on the horizon, enjoy bank holiday....
svenice7
07/5/2020
18:24
Delayed from yesterday - look at the trade number and time.
talk2dubya
07/5/2020
17:46
I think that was this morning, but strangely not recorded in total trades from what I can see?
the real capitalcity
07/5/2020
17:37
A 1 million trade at 60.... so a buy ?
peachie 74
07/5/2020
17:27
Ah there they are - another million trade.
talk2dubya
07/5/2020
17:21
They took a day off yesterday because it’s a bank holiday weekend?
talk2dubya
07/5/2020
17:20
Death kiss defo lol. They’ll be back selling next week.
dealer55
07/5/2020
17:07
This is probably the kiss of death, but has anyone else noticed a distinct lack afterhours sells so far?
talk2dubya
07/5/2020
16:34
So much for super Thursday lol.

My smoker arrived today so that's me sorted for the long weekend!

Have a good one all. Slowly getting there.

adman50
07/5/2020
16:30
No blue Thursday. Everyone have a good weekend. Back on Monday
vitec
07/5/2020
16:26
That presentation was a trip down memory lane for me, a couple of very good questions during the Q&As 🙂🙂
timbo003
07/5/2020
16:17
You sound like you've got balls of steel.Building up for a happy finish 62p imo
bobaxe1
07/5/2020
14:58
3 years ago that presentation
pgaffney
07/5/2020
14:52
Unless I'm incorrect, this presentation was actually from a couple of years back, but it still makes interesting viewing. RM talks about getting to a point where someone comes along to buy them out in the same way as Roche brought a company for 8 billion. (not quite the same league!) A tie up or buy out by AZN would be my best guess, as they already have a good relationship with them, and could easily provide AZN with close access to a strong research pipe line and would reduce costs for them by way of licence payments. Only my opinion.
the real capitalcity
07/5/2020
14:42
That's me back in
fatnacker
07/5/2020
14:39
Paradise City,
90% of that paper went well over my head, but it reads as if RM wrote it himself!

wetdream
07/5/2020
14:37
Well......it was uploaded 2 days ago by Shares Magazine but not sure how old....
markinvestor
07/5/2020
14:20
Apologies if this has already been shared, but an interesting presentation made 2 days ago by Richard for Shares Magazine
markinvestor
07/5/2020
14:19
New research report - WOW Very interestingToday 14:12Report: Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions by Department of Internal Medicine, Lyon University Hospital, Lyon, France 4th May 2020. Courtesy of a poster on lse !!This is a long report so it will take some time to digest for those interested. But it has some very positive analysis regarding Interferon-beta treatment in SARS-CoV-2. I have selected highlighted some of the key points below. The report highlights that interferon INHALATION can lower the infection rate - supporting the SNG001 nebuliser method. Very interesting. IFN-a and IFN-ß have emerged as potentially effective drugs against SARS-CoV-2.IFN-a and -ß have very systematically demonstrated robust efficacy against coronavirusesIFN-ß1b and IFN-ß1a are the most potent subtypes for SARS-CoV inhibition (probably even more for SARS-CoV-2)type-I IFN must be administered as soon as possible after infection (ideally before symptom onset) IFN-a inhalation can lower SARS-CoV-2 infection rate and serve in prophylaxis or treatmentIn the very early stages of the disease, treatment should focus on reducing viral load either by specific antivirals or by stimulating type-I IFNThe report is interesting, and it is clear that medical institutions are crying out for robust data from clinical trials that are well controlled and double-blind.
paradise city
07/5/2020
14:12
Now back on the bid. Won't be long until they are back on the offer!!
vitec
07/5/2020
14:11
It is clever what they are doing to suppress the share price They go on the bid, buy the shares actively and then go back on the offer to sell what they have purchased.
vitec
07/5/2020
14:07
That’s an interesting turn of events then.
talk2dubya
07/5/2020
13:51
It is BEGO that are actively bidding for the stock. Most of the day they have been on the offer.
vitec
Chat Pages: Latest  271  270  269  268  267  266  265  264  263  262  261  260  Older

Your Recent History

Delayed Upgrade Clock